Mycophenolate mofetil: a magic bullet for lupus?
McCune, W.J.; Riskalla, M.M.
Journal of Rheumatology 32(6): 967-970
2005
ISSN/ISBN: 0315-162X PMID: 15940751 Document Number: 589852
Document emailed within 1 workday
Related Documents
Carl, S.; Wiesel, M.; Staehler, G. 1998: Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group Der Urologe. Ausg. a 37(3): 282-286Wallman, L.; Stewart, G.; Chapman, J.; O'Connell, P.; Fulcher, D. 2000: Mycophenolate mofetil for treatment of refractory lupus nephritis: four pilot cases Australian and New Zealand Journal of Medicine 30(6): 712-715
Fu, Y.F.; Liu, G.L. 2001: Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine Clinical Nephrology 55(4): 318-321
Hrvacevic, R.; Ignjatovic, L.; Vavic, N. 2001: Use of mycophenolate mofetil in kidney transplantation Vojnosanitetski Pregled 58(4): 415-419
Weber, L.T.; Höcker, B.; Mehls, O.; Tönshoff, B. 2003: Mycophenolate mofetil in pediatric renal transplantation Minerva Urologica e Nefrologica 55(1): 91-99
Frutos, M.A.; López, V.; Alférez, M.J.; Aranda, P. 2005: Mycophenolate mofetil in high risk IgA glomerulonephritis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 25(4): 387-392
Tursen, U.; Api, H.; Kaya, T.; Ikizoglu, G. 2004: Treatment of lichen planopilaris with mycophenolate mofetil Dermatology Online Journal 10(1): 24
Reinke, T. 2010: Defined contribution. Magic bullet? Managed Care 19(9): 12-16; 19
Grundmann-Kollmann, M.; Podda, M.; Ochsendorf, F.; Boehncke, W.H.; Kaufmann, R.; Zollner, T.M. 2001: Mycophenolate mofetil is effective in the treatment of atopic dermatitis Archives of Dermatology 137(7): 870-873
Jose, M.D.; Roake, J.A.; Robson, R.A. 2000: The role of mycophenolate mofetil in chickenpox after renal transplantation Transplantation 70(1): 242-243
Sollinger, H.W. 1996: Update on preclinical and clinical experience with mycophenolate mofetil Transplantation Proceedings 28(6 Suppl. 1): 24-29
Zhao, M.; Chen, X.; Chen, Y.; Liu, Z.; Liu, Y.; Lu, F.; Zhang, Y.; Wang, H. 2001: Mycophenolate mofetil in the treatment of primary nephrotic syndrome Zhonghua Yi Xue Za Zhi 81(9): 528-531
Pedersen, E.B. 1997: Mycophenolate mofetil. a new immunosuppressive agent in transplantation therapy Ugeskrift for Laeger 159(30): 4664-4668
Parotte, M.C.; Bovy, C.; Krzesinski, J.M. 2007: Benefits of mycophenolate mofetil in non-transplant kidney diseases Revue Medicale Suisse 3(122): 1899-1901; 1903-1905
Kumar, L.; Verma, S.; Prasad, D.Nandan.; Bhardwaj, A.; Vaidya, B.; Jain, A.Kumar. 2015: Nanotechnology: a magic bullet for HIV AIDS treatment Artificial Cells Nanomedicine and Biotechnology 43(2): 71-86
Smadja, D.; Lemaire, P.; Atkhen, N. 2003: Abnormal chromatin clumping syndrome during treatment with mycophenolate mofetil Annales de Biologie Clinique 61(4): 463-465
Friedrich, J.; Erhard, J. 1994: Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation Zentralblatt für Chirurgie 119(1): 48-49
Barré, J.; Simon, N.; Tillement, J.P. 1997: Mycophenolate mofetil, a new immunosuppressive agent. Is pharmacokinetic monitoring justified? Therapie 52(2): 139-142
Yeo, P.M.; Ang, C.C. 2017: Jaw Pain in a Pemphigus Patient on Prednisolone, Mycophenolate Mofetil and Denosumab Annals of the Academy of Medicine Singapore 46(8): 329-330
Hrvacević, R.; Ignjatović, L.; Vavić, N.; Dimitrijević, J.; Drasković-Pavlović, B.; Dujić, A.; Elaković, D.; Kronja, G.; Marić, M. 2001: Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity Vojnosanitetski Pregled 58(2): 157-160